Tecan will manufacture Enigma's new point-of-care molecular diagnostic instrument under a five-year deal.
Chris Wagner, Brad Popovich, Jorge Garces, Greg Hamilton, Nick Williams, Darren Hall
The British molecular diagnostics firm also announced executive appointments for both the US and European operations.
The firms will develop tests to run on Enigma's ML platform. As part of the alliance, GSK will make an equity investment in the molecular diagnostics startup.
Enigma Diagnostics gained access to two Roche patents for use in its multiplex PCR tests for human and animal diseases.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.
A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.
An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.
In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.